TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,513,000 | -44.9% | 3,545,000 | -45.8% | 0.01% | -62.5% |
| Q3 2020 | $6,376,000 | -73.0% | 6,545,000 | +8.3% | 0.02% | -73.3% |
| Q2 2020 | $23,625,000 | +290.6% | 6,045,000 | -7.0% | 0.06% | +233.3% |
| Q1 2020 | $6,048,000 | -2.2% | 6,500,000 | 0.0% | 0.02% | +80.0% |
| Q4 2019 | $6,181,000 | – | 6,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |